Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Family and advocacy groups urge insurance coverage for Alzheimer's biomarker testing
Summary
A public commenter and Alzheimer's Association representative urged the committee to expand access to biomarker testing and treatments for Alzheimer's disease, citing personal experience and organization estimates of individual and state cost savings; committee members asked finance staff to analyze premium and appropriation impacts.
Public commenter John Powell described his late wife’s decline from probable Alzheimer’s and told the committee that recent approvals and diagnostic advances change the calculus for care. "My wife, Judy Saddlebaum, ... her life ended 2 and a half years ago from dementia, probably Alzheimer's," Powell said, and he told members that had blood‑based biomarkers and newer therapies been available earlier, they might have altered her course.
Jenny Morgan of the Alzheimer's…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
